Author:
Csoma Zsuzsanna,Gál Zsófia,Gézsi András,Herjavecz Irén,Szalai Csaba
Abstract
AbstractBackground: Severe asthma (SA) database was established in Hungary to estimate the prevalence of SA and to define and analyze clinical phenotypes of the patients. Methods: SA questionnaires were sent out to 143 public pulmonary dispensaries specialized for diagnosing and caring pulmonary patients. Data of 520 SA patients were evaluated. Results: The prevalence of SA within the asthmatic population in Hungary was 0.89%. The mean age of patients were 56.4 ± 13.4 years, SA were more frequent in females (64%), the prevalence of allergy was 56.6%, 72.1% of patients had persistent airflow limitation (FEV1 < 80%), 37.9% severe airway obstruction (FEV1 ≤ 60%), 33.6% required systemic corticosteroid maintenance therapy, 21.5% had salicylate intolerance and 43.2% rhinosinusitis. A Bayesian dependency network was calculated which revealed several interdependencies between the characteristics. E.g. there was a strong association between salicylate intolerance and rhinosinusitis, more patients received regular systemic corticosteroid treatment who had salicylate intolerance and the proportion of salicylate intolerance was significantly higher in females. Conclusion: The prevalence of SA was determined in Hungary which was lower than in other studies. Using a Bayesian-based network analysis several interdependencies were revealed between patient characteristics.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Chastek, B. et al. Economic burden of illness among patients with severe asthma in a managed care setting. J. Manag. Care Spec. Pharm. 22, 848–861 (2016).
2. Tough, S. C. et al. Features that distinguish those who die from asthma from community controls with asthma. J. Asthma 35, 657–665 (1998).
3. Kupczyk, M. & Wenzel, S. US and European severe asthma cohorts: What can they teach us about severe asthma? Journal of Internal Medicine 272, 121–132 (2012).
4. Anderson, G. P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. The Lancet 372, 1107–1119 (2008).
5. ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur. Respir. J. 22, 470–7 (2003).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献